Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-21-000511
Filing Date
2021-02-19
Accepted
2021-02-19 17:10:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13G sc13g07422infi_02192021.htm SC 13G 277528
2 JOINT FILING AGREEMENT ex991to13g07422infi_02192021.htm EX-99.1 10584
  Complete submission text file 0000921895-21-000511.txt   289938
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60943 | Film No.: 21657061
SIC: 2834 Pharmaceutical Preparations